Flecainide contraindications

Revision as of 17:32, 11 March 2014 by ShiSheng (talk | contribs)
Jump to navigation Jump to search
Flecainide
FLECAINIDE ACETATE® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Flecainide
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

Flecainide acetate is contraindicated in patients with pre-existing second- or third-degree AV block, or with right bundle branch block when associated with a left hemiblock (bifascicular block), unless a pacemaker is present to sustain the cardiac rhythm should complete heart block occur. Flecainide acetate is also contraindicated in the presence of cardiogenic shock or known hypersensitivity to the drug.


[1]

References

  1. "FLECAINIDE ACETATE TABLET [APOTEX CORP.]". Retrieved 11 March 2014.

Template:Antiarrhythmic agents